Dyadic Intervention for Women at Risk for Postpartum Depression and their Infants

对有产后抑郁症风险的妇女及其婴儿的二元干预

基本信息

  • 批准号:
    7873266
  • 负责人:
  • 金额:
    $ 28.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-01 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application is in response to PA-09-175 Women's Mental Health in Pregnancy and the Postpartum Period. The goal of this exploratory/development (R21) project is to further develop, pilot test, and refine a novel dual-focused mother-infant intervention to prevent/decrease maternal postpartum depression (PPD) and improve aspects of mother-infant relationships and child development outcomes. Approximately 10-15% of women experience PPD after the birth of a baby, with serious negative consequences for maternal well-being, the mother-infant relationship, and subsequent child development. Most current PPD treatments focus exclusively on maternal outcomes, neglect the mother-infant relationship, and thus do not result in improvements in relationship or child outcomes. No study has yet addressed the dual problems of maternal depression and mother-infant relationship dysfunction in an integrated way. The proposed project innovatively addresses this critical research gap by targeting PPD and the associated mother-infant relationship dysfunction concurrently in a theoretically and clinically based early dyadic intervention that consists of: (a) an insight- oriented and supportive relationship-based mother-infant psychotherapeutic component utilizing the infant as an integral part of the therapy, and (b) a developmentally-based infant-oriented component designed to enhance maternal sensitive responsiveness and promote positive mother-infant interactions. Our specific aims are to: (1) Develop the intervention protocol and refine it as appropriate after testing its feasibility with 5 mother-infant dyads; (2) Assess the efficacy of the intervention on the primary outcomes of prevention or reduction of PPD and enhancing the quality of mother-infant interaction at post-intervention, 6 months, and 1 year postpartum follow-ups; and (3) Explore the effects of the intervention on secondary outcomes of maternal anxiety, parenting stress, maternal self-esteem, maternal attachment to the infant, child attachment security, and child cognitive development at post-intervention and follow-up time points. After developing the intervention and refining it based on expert consultation and findings from the initial feasibility testing, we will test its efficacy using a sample of 60 women determined to be at-risk for PPD due to elevated depression scores at 1 week postpartum and their infants. Dyads will be randomly assigned to the intervention or control group. The home-based intervention will consist of 8 mother-infant sessions delivered by specially trained nurses over the first 3 months postpartum. Control group will receive a short educational intervention followed by usual care plus maternal depression monitoring by phone on a schedule comparable to the intervention visits. Maternal and mother-infant outcomes will be measured at baseline, post-intervention, and at two follow- up points. Infant outcomes will be assessed at 1 year of age. Repeated measures analysis of variance will be used to determine intervention effects. If successful, findings from this study will inform the development of a future R01 proposal to conduct a larger randomized trial of the intervention. PUBLIC HEALTH RELEVANCE: Postpartum depression (PPD) is a major public health concern that affects approx 10-15% of mothers with serious negative consequences for not only the mothers, but also the mother-infant relationship and child development. The goal of the proposed project is to develop and assess the feasibility and efficacy of a novel dual-focused mother-infant intervention by specially trained nurses to prevent/decrease maternal postpartum depression and associated mother-infant relationship dysfunction. If shown to be effective, this intervention would provide a new early-stage treatment option for PPD that would hold great benefit for mothers and infants and could be easily adapted for widespread public use for at-risk mother-infant dyads.
描述(申请人提供):本申请是针对PA-09-175《妇女孕期和产后心理健康》而提出的。这一探索性/发展性(R21)项目的目标是进一步开发、试点测试和改进一种新的双重点母婴干预措施,以预防/减少产妇产后抑郁(PPD),并改善母婴关系和儿童发育结果的各个方面。大约10%-15%的妇女在婴儿出生后经历产后抑郁,对母亲的福祉、母婴关系和随后的儿童发育造成严重的负面后果。目前的产后抑郁治疗大多只关注母亲的结局,忽视母婴关系,因此不能改善关系或改善孩子的结局。还没有研究以一种综合的方式解决母亲抑郁和母婴关系障碍的双重问题。拟议的项目创新性地解决了这一关键的研究空白,在基于理论和临床的早期二元干预中同时针对产后抑郁和相关的母婴关系障碍,该干预包括:(A)以洞察力和支持性关系为基础的母婴心理治疗部分,将婴儿作为治疗的组成部分;(B)以发育为基础的婴儿部分,旨在增强母亲的敏感反应和促进积极的母婴互动。我们的具体目标是:(1)制定干预方案,并在对5对母婴进行可行性测试后进行适当的修改;(2)评估干预对预防或减少产后抑郁的主要结果的有效性,并在干预后、6个月和1年的产后随访中提高母婴互动的质量;以及(3)探讨干预对母亲焦虑、育儿压力、母亲自尊、母亲对婴儿的依恋、儿童依恋安全和儿童认知发展的影响。在开发了干预措施并根据专家咨询和初步可行性测试的结果进行改进后,我们将使用60名被确定为产后1周抑郁评分升高的PPD高危妇女及其婴儿的样本来测试其有效性。二元组将被随机分配到干预组或对照组。家庭干预将包括8次母婴会议,由受过专门培训的护士在产后的头3个月内进行。对照组将接受短暂的教育干预,然后进行常规护理,并通过电话监测母亲的抑郁,时间安排与干预访问相当。产妇和母婴结局将在基线、干预后和两个随访点进行衡量。婴儿的结局将在1岁时进行评估。将使用重复测量方差分析来确定干预效果。如果成功,这项研究的结果将为未来R01提案的发展提供信息,以进行更大规模的干预随机试验。 公共卫生相关性:产后抑郁症(PPD)是一种主要的公共卫生问题,影响到大约10%-15%的母亲,不仅对母亲,而且对母婴关系和儿童发展都有严重的负面影响。拟议项目的目标是开发和评估由受过专门培训的护士进行的双重点母婴干预的可行性和有效性,以预防/减少产妇产后抑郁和相关的母婴关系障碍。如果被证明是有效的,这种干预将为产后抑郁提供一种新的早期治疗选择,将对母亲和婴儿产生巨大的好处,并可以很容易地适应公众对高危母婴的广泛使用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

janice goodman其他文献

janice goodman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('janice goodman', 18)}}的其他基金

Dyadic Intervention for Women at Risk for Postpartum Depression and their Infants
对有产后抑郁症风险的妇女及其婴儿的二元干预
  • 批准号:
    8076218
  • 财政年份:
    2010
  • 资助金额:
    $ 28.91万
  • 项目类别:
Parental Postpartum Depression & the Family System
父母产后抑郁症
  • 批准号:
    6539470
  • 财政年份:
    2002
  • 资助金额:
    $ 28.91万
  • 项目类别:
Parental Postpartum Depression & the Family System
父母产后抑郁症
  • 批准号:
    6406192
  • 财政年份:
    2001
  • 资助金额:
    $ 28.91万
  • 项目类别:
Parental Postpartum Depression & the Family System
父母产后抑郁症
  • 批准号:
    6649229
  • 财政年份:
    2001
  • 资助金额:
    $ 28.91万
  • 项目类别:
Parental Postpartum Depression & the Family System
父母产后抑郁症
  • 批准号:
    6792648
  • 财政年份:
    2001
  • 资助金额:
    $ 28.91万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.91万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了